CN106668607A - 一种治疗痛风的中药 - Google Patents
一种治疗痛风的中药 Download PDFInfo
- Publication number
- CN106668607A CN106668607A CN201710077470.1A CN201710077470A CN106668607A CN 106668607 A CN106668607 A CN 106668607A CN 201710077470 A CN201710077470 A CN 201710077470A CN 106668607 A CN106668607 A CN 106668607A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- radix
- gout
- herba
- wine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 59
- 201000005569 Gout Diseases 0.000 title claims abstract description 30
- 210000000582 semen Anatomy 0.000 claims abstract description 47
- 238000002360 preparation method Methods 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000007788 liquid Substances 0.000 claims abstract description 26
- 229940079593 drug Drugs 0.000 claims abstract description 18
- 238000005202 decontamination Methods 0.000 claims description 27
- 230000003588 decontaminative effect Effects 0.000 claims description 27
- 241000903946 Clematidis Species 0.000 claims description 22
- 239000008517 radix Trichosanthis Substances 0.000 claims description 15
- 241000218176 Corydalis Species 0.000 claims description 14
- 238000002386 leaching Methods 0.000 claims description 11
- 239000012467 final product Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 7
- 239000006187 pill Substances 0.000 claims description 6
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims description 4
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims description 4
- 239000002023 wood Substances 0.000 claims description 3
- 239000003390 Chinese drug Substances 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 241000219112 Cucumis Species 0.000 claims 2
- 239000002994 raw material Substances 0.000 abstract description 9
- 206010030113 Oedema Diseases 0.000 abstract description 7
- 208000001431 Psychomotor Agitation Diseases 0.000 abstract description 5
- 206010038743 Restlessness Diseases 0.000 abstract description 5
- 210000003205 muscle Anatomy 0.000 abstract description 5
- 230000035922 thirst Effects 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 4
- 230000001939 inductive effect Effects 0.000 abstract description 4
- 150000007524 organic acids Chemical class 0.000 abstract description 4
- 206010012735 Diarrhoea Diseases 0.000 abstract description 2
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 238000010791 quenching Methods 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 238000002791 soaking Methods 0.000 abstract 2
- 240000003915 Lophatherum gracile Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 238000009835 boiling Methods 0.000 abstract 1
- 238000004140 cleaning Methods 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 239000012535 impurity Substances 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 230000000171 quenching effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 37
- 238000011282 treatment Methods 0.000 description 22
- 208000002193 Pain Diseases 0.000 description 20
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 18
- 230000036407 pain Effects 0.000 description 18
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 17
- 229940116269 uric acid Drugs 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 16
- 239000008280 blood Substances 0.000 description 16
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 11
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 11
- 208000004880 Polyuria Diseases 0.000 description 9
- 230000035619 diuresis Effects 0.000 description 9
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 8
- 230000006698 induction Effects 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 241000219780 Pueraria Species 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 235000011949 flavones Nutrition 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 4
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 201000001431 Hyperuricemia Diseases 0.000 description 4
- 230000001142 anti-diarrhea Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 235000021251 pulses Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 210000002683 foot Anatomy 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 210000000878 metatarsophalangeal joint Anatomy 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- 244000241257 Cucumis melo Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 241000219138 Luffa Species 0.000 description 2
- 235000003956 Luffa Nutrition 0.000 description 2
- 206010033664 Panic attack Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 2
- 229960003459 allopurinol Drugs 0.000 description 2
- 210000003423 ankle Anatomy 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 238000009534 blood test Methods 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical group C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000021022 fresh fruits Nutrition 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 208000019906 panic disease Diseases 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 229940102535 prednisone 20 mg Drugs 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000003813 thumb Anatomy 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 description 1
- XDKLKFULWJYRCB-UHFFFAOYSA-N 7,9-dihydro-3h-purine-2,6,8-trione;sodium Chemical compound [Na].N1C(=O)NC(=O)C2=C1NC(=O)N2 XDKLKFULWJYRCB-UHFFFAOYSA-N 0.000 description 1
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 101100165177 Caenorhabditis elegans bath-15 gene Proteins 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 241000252230 Ctenopharyngodon idella Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010073508 Drug reaction with eosinophilia and systemic symptoms Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000004302 Microvascular Angina Diseases 0.000 description 1
- 208000026018 Microvascular coronary artery disease Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241001092500 Photinia x fraseri Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 102100028255 Renin Human genes 0.000 description 1
- 108090000783 Renin Proteins 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010046337 Urate nephropathy Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229940039750 aconitine Drugs 0.000 description 1
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002908 adrenolytic effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001004 anti-acetylcholinic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000002763 arrhythmic effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000003797 carpal joint Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000001916 dieting Nutrition 0.000 description 1
- 230000037228 dieting effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000007937 eating Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000007849 functional defect Effects 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002338 glycosides Chemical group 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000000971 hippocampal effect Effects 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000008407 joint function Effects 0.000 description 1
- 208000018934 joint symptom Diseases 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000004936 left thumb Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000036581 peripheral resistance Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229940102565 probenecid 500 mg Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000004144 purine metabolism Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 210000001210 retinal vessel Anatomy 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000012201 sexual and gender identity disease Diseases 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000005182 tip of the tongue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/17—Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开一种治疗痛风的中药,取葛根、车前子、淡竹叶、丝瓜络、金钱草,去杂质,洗净,用清水浸润,切片,置于酒液中洗浸,日晒七天、晚上放置在户外七晚为一次制备过程,如此连续9次后再晒干备用;所制原料药一起加水煎煮,大火煮沸后小火煎,过滤,收集药液,即得汤剂。而本品不仅具有升阳解肌,除烦止渴、通经活络,清热解毒,利尿消肿、渗湿止泻、驱风、抗炎、降酸等功能治疗痛风;并能提高机体抵抗能力和免疫力。
Description
技术领域
本发明涉及一种中药,尤其是一种治疗痛风的中药。
背景技术
痛风是高尿酸血症所引起的一种关节炎。尿酸为人类嘌呤代谢的终产物,在血中溶解,大部分经过肾脏由尿排泄至体外。当体内代谢紊乱、或摄取过多的高嘌呤食物,导致尿酸量增加,而肾脏对尿酸排泄不畅(患者占80-85%),使尿酸在血液中大量积蓄,导致高尿酸血症。当血尿酸浓度达到饱和,尿酸钠盐便以针状结晶析出,沉积在关节、肌腱、肾脏等部位,导致痛风。痛风急性发作十分疼痛,会引起尿酸盐肾病和尿酸性尿路结石,及导致肾功能不全;还会引起关节变形。痛风及高尿酸血症显著地与高血脂、高血压、糖尿病、动脉粥样硬化等疾病相关,严重影响人们的健康和生活质量,必须治疗。
发明内容
本发明的目的在于提供一种依据中医“治病必求于本”的原则,抓住痛风疾病的根本原因,中医属于“痹症”范畴,实验室生化检查(高尿酸)的有效治疗痛风的中药及其制备方法。
本发明的技术方案为:组方一:一种治疗痛风的中药,该中药的重量组份为: 葛根10-40、车前子5-20、淡竹叶5-20、丝瓜络5-20、金钱草8-20。其制备步骤:取葛根、车前子、淡竹叶、丝瓜络、金钱草,去杂质,洗净,用清水浸润,切片,置于酒液中洗浸7小时,日晒七天、晚上放置在户外七晚为一次制备过程,如此连续9次后再晒干备用;所制原料药一起加水煎煮,大火煮沸后小火煎 25-47分钟,过滤,收集药液,即得汤剂。
组方二:一种治疗痛风的中药,该中药的重量组份还包括: 葛根 10-40、车前子5-20、淡竹叶5-20、丝瓜络5-20、金钱草8-20、薏米仁10-40、木瓜8-20 威灵仙8-20。其制备步骤:(1)取葛根、车前子、淡竹叶、丝瓜络、金钱草,去杂质,洗净,用清水浸润,切片,置于酒液中洗浸7小时,日晒七天、晚上放置在户外七晚为一次制备过程,如此连续9次后再晒干备用; (2)将薏米仁、木瓜、威灵仙,去杂质,洗净,用黄酒煮,待酒吸尽后,取出,用 湿草纸包裹三层,置于热灰中,煨至外层纸枯焦时取出,除去纸,晾干;所制原料药一起加水煎煮,大火煮沸后小火煎25-47分钟,过滤,收集药液,即得汤剂。
组方三:一种治疗痛风的中药,该中药的重量组份进一步还包括: 葛根 10-40、车前子8-20、淡竹叶8-20、丝瓜络8-20、金钱草8-20、薏米仁10-40、木瓜8-20、威灵仙8-20、羌活10-15、天花粉10-15、川芎10-15、延胡索10-15。其制备步骤:(1)取葛根、车前子、淡竹叶、丝瓜络、金钱草,去杂质,洗净,用清水浸润,切片,置于酒液中洗浸7小时,日晒七天、晚上放置在户外七晚为一次制备过程,如此连续9次后再晒干备用; (2)将薏米仁、木瓜、威灵仙,去杂质,洗净,用黄酒煮,待酒吸尽后,取出,用湿草纸包裹三层,置于热灰中,煨至外层纸枯焦时,取出,除去纸,晾干;(3)将羌活、天花粉、川芎、延胡索,去杂质,洗净,用黄酒将车前子拌匀,用文火炒至略带火色。每100kg羌活用黄酒12.5kg;步骤(4)与步骤(1)(2)(3)所制原料药一起加水煎煮,大火煮沸后小火煎25-47分钟,过滤,收集药液,即得汤剂。
所述中药剂型可以选取为汤剂、胶囊剂、颗粒剂或丸剂。
本发明的三种组方,以组方一升阳解肌、清热利尿、消肿、除烦、通经活络、解毒、散瘀消肿为基础,依次递进,组方二在组方一基础上增加:薏米仁、木瓜、威灵仙加强了主湿痹、祛风除湿,通络止痛的功效;组方三在组方二基础上增加羌活、天花粉、川芎、延胡索进行配伍,进一步加强了祛风除湿、活血行气止痛的功效。
本发明的优点在于:本品系由葛根、车前子、淡竹叶、丝瓜络、金钱草、薏米仁、木瓜、威灵仙、羌活、天花粉、川芎、延胡索等中药组成。
而本品不仅具有升阳解肌,除烦止渴、通经活络,清热解毒,利尿消肿、渗湿止泻、驱风、抗炎、降酸等功能治疗痛风;并能提高机体抵抗能力和免疫力;本发明的技术方案一的基础上,增加:羌活、天花粉、川芎、延胡索除痹止痛、祛风除湿,通络止痛、活血行气止痛的功效;可长期服用,无毒副作用。
葛根的功效: 升阳解肌,透疹止泻,除烦止渴。治伤寒、温热头痛项强,烦热消渴,泄泻,痢疾,癍疹不透,高血压,心绞痛,耳聋。 葛根的作用: 1、对平滑肌的作用 葛根中的大豆甙元具有抗乙酰胆碱作用,能够明显收缩平滑肌,被认为是葛根解痉作用的主要成分。2、对冠状循环的作用 葛根水煎剂、醇浸膏、总黄酮和葛根素均有明显的扩张冠状血管的作用,能使冠血流量增加,血管阻力降低。3、对心肌梗塞和心律失常的作用 葛根醇浸膏、大豆甙元和葛根素均有明显的对抗乌头碱和氯化钡诱发的心律失常作用,葛根素还能明显缩短氯彷、肾上腺素诱发的家兔心律失常时间,葛根素能明显缩小心肌梗塞范围,被认为是一种β-肾上腺素受体阻滞剂。4、对心脏功能和心肌代谢的影响 葛根总黄酮和葛根素能减慢心率,降低心脏总外周阻力,减少心肌耗氧量;提高心肌工作效率.葛根素还能明显减少缺血引起的心肌乳酸的产生,改善梗塞心肌的代谢。 5、 对血压和外周血管的作用 葛根总葛酮和葛根素能使血浆肾素活性和血管紧张素显著降低,血压下降.葛根素对微循环障碍有明显的改善作用,主要表现为增加微血管运动的振幅和提高局部微血流量;葛根总黄酮具有明显扩张脑血管的作用,改善脑微循环和外周循环.据报道,葛根素还能改善视网膜血管末稍单位的阻滞状态,从而提高视功能。6、抑制血小板聚集作用 葛根素能抑制二磷酸腺苷(ADP)诱导和5-HT(5-羟色胺)与ADP联合诱导的人和动物的血小板聚集;另外,葛根素还能明显抑制由凝血酶诱导的血小板中5-HT的释放,具有抗血栓形成作用。7、降血糖的作用 葛根素能对抗肾上腺素的升血糖作用,具有一定的降血糖能力。8、对体温的影响 葛根总黄酮对内毒素致体温升高具有转持久而明显的降温作用,临床上常用于外感发热诸症。9、对记忆的影响葛根总黄酮和醇提物能提高大鼠大脑皮层和海马乙酰胆碱含量,并降低海马乙酰胆碱转移酶活性,对抗东莨碱所效的大鼠记忆获得性障碍,这说明,葛根具有一定的改善学习记忆的能力。
车前子的功效:清热利尿;渗湿止泻;明目;祛痰。
淡竹叶的功效:具有清热除烦,利尿通淋的功效十主治热病烦渴,口舌生疮,牙龈肿痛,小儿惊啼,肺热咳嗽,胃热呕哕,小便赤涩淋浊。
丝瓜络的功效:通经活络,清热解毒,利尿消肿,止血。主治胸胁胀痛,风湿痹痛,筋脉拘挛,女子经闭,乳汁不通,痰热咳嗽,热毒痈肿,痔漏,水肿,小便不利,便血,崩漏。
金钱草的功效:功效主治:金钱草是一种常见植物,而且是一种中药材,主要功效可预防结石和利胆排石,可以说对结石有非常好的治疗和预防效果。利水通淋、清热解毒、散瘀消肿、清利湿热、沙淋、尿涩作痛、黄疸尿赤、痈肿疔疮。主治肝胆及泌尿系结石;热淋、肾炎水肿、湿热黄疸、疮毒痈肿、毒蛇咬伤、跌打损伤。
薏米仁的功效:主湿痹,利肠胃,消水肿,润泽肌肤,美白补湿,除斑,凉性清热消暑。种仁不仅为优良营养品,且具有利尿和抗癌作用。适用于脚气水肿,癌瘤初期。其根为驱蛔药。其性寒凉,容易伤脾胃,必寒必温之。
木瓜的功效:药用木瓜鲜果中含有较多的单宁和有机酸,糖含量相对较低,使其口感酸涩,不宜生食。但其果实营养丰富,富含维生素。木瓜中酸类成分包括苹果酸、枸橼酸、酒石酸等,这些有机酸都具有纯正的酸味,经过适当稀释并辅以一定的甜味剂如蔗糖或蜂蜜后,可制成风味独特的产品。
威灵仙的功效:威灵仙药用木瓜鲜果中含有较多的单宁和有机酸,糖含量相对较低,使其口感酸涩,不宜生食。但其果实营养丰富,富含维生素。威灵仙的功效:功效:祛风除湿,通络止痛。
羌活的功效羌活可以用于治疗风寒感冒的解表散寒,用于祛风和胜湿,并且还可以止痛。
天花粉的功效:生津止渴、清热泻火除烦 和消肿排脓是天花粉的功效
川芎、延胡索的共同功效:活血行气止痛,用于治疗血瘀气滞诸痛证、二者都是 血中气滞要药。川芎的其他功效:祛风,用于头痛、风湿痹痛、 风热、 风寒、 风湿 、血虚、 血瘀。
车前草的功效:止咳化痰、止泻、利尿、抗炎。
具体实施方式
一种治疗痛风的中药,主要由下列原料药制备而成,均为质量份 :葛根 、 车前子、淡竹叶、 丝瓜络、金钱草、薏米仁、木瓜、威灵仙。
组方一:葛根 10-40、车前子5-20、淡竹叶5-20、丝瓜络5-20、金钱草8-20。
组方二:葛根 10-40、车前子8-20、淡竹叶8-20、丝瓜络8-20、金钱草8-20、薏米仁10-40、木瓜8-20、威灵仙8-20。
组方三:葛根 10-40、车前子8-20、淡竹叶8-20、丝瓜络8-20、金钱草8-20、薏米仁10-40、木瓜8-20、威灵仙8-20、羌活10-15、天花粉10-15、川芎10-15、延胡索10-15。
汤剂实例一:
汤剂的其制备方法是:(1)10公斤葛根、8公斤车前子、8公斤淡竹叶、8公斤丝瓜络、8公斤金钱草、去杂质,洗净,用清水浸润,切片,置于酒液中洗浸7小时,日晒七天、晚上放置在户外七晚为一次制备过程,如此连续9次后再晒干备用; (2)将40公斤薏米仁、20公斤木瓜、20公斤威灵仙去杂质,洗净,用黄酒煮,待酒吸尽后,取出,用湿草纸包裹三层,置于热灰中,煨至外层纸枯焦时,取出,除去纸,晾干;(3)将15公斤羌活、15公斤天花粉、15公斤川芎、15公斤延胡索去杂质,洗净,用黄酒将车前子拌匀,用文火炒至略带火色。每100kg羌活用黄酒12.5kg。步骤(4)与步骤(1)(2)(3)所制原料药一起加水煎煮,大火煮沸后小火煎 25-47分钟(优选的,小火煎 30-42分钟;更加优选的,小火煎 36 分钟),过滤,收集药液,即得汤剂。
汤剂实例二:
汤剂的其制备方法是:(1)取40公斤葛根、20公斤车前子、20公斤淡竹叶、20公斤丝瓜络、20公斤金钱草去杂质,洗净,用清水浸润,切片,置于酒液中洗浸7小时,日晒七天、晚上放置在户外七晚为一次制备过程,如此连续9次后再晒干备用;(2)将10公斤薏米仁、8公斤木瓜、8公斤威灵仙去杂质,洗净,用黄酒煮,待酒吸尽后,取出,用湿草纸包裹三层,置于热灰中,煨至外层纸枯焦时,取出,除去纸,晾干;(3)将10公斤羌活、10公斤天花粉、10公斤川芎、10公斤延胡索去杂质,洗净,用黄酒将车前子拌匀,用文火炒至略带火色。每100kg羌活用黄酒12.5kg。步骤(4)与步骤(1)(2)(3)所制原料药一起加水煎煮,大火煮沸后小火煎25-47分钟(优选的,小火煎 30-42分钟;更加优选的,小火煎 36 分钟),过滤,收集药液,即得汤剂。
汤剂实例三:
汤剂的其制备方法是:(1)取20公斤葛根、10公斤车前子、10公斤淡竹叶、10公斤丝瓜络、10公斤金钱草去杂质,洗净,用清水浸润,切片,置于酒液中洗浸7小时,日晒七天、晚上放置在户外七晚为一次制备过程,如此连续9次后再晒干备用; (2)将10公斤薏米仁、10公斤木瓜、10公斤威灵仙去杂质,洗净,用黄酒煮,待酒吸尽后,取出,用湿草纸包裹三层,置于热灰中,煨至外层纸枯焦时,取出,除去纸,晾干;(3)将10公斤羌活、10公斤天花粉、10公斤川芎、10公斤延胡索去杂质,洗净,用黄酒将车前子拌匀,用文火炒至略带火色。每100kg羌活用黄酒12.5kg。步骤(4)与步骤(1)(2)(3)所制原料药一起加水煎煮,大火煮沸后小火煎25-47分钟(优选的,小火煎 30-42分钟;更加优选的,小火煎 36 分钟),过滤,收集药液,即得汤剂。
丸剂的制备方法,汤剂步骤(4)加水量为总原料药质量的7-9倍(优选的,加水量为总原料药质量的7.5-8.5 倍;更加优选的,加水量为总原料药质量的8倍)。所述的治疗痛风的中药制剂,将其制成药学上可接受的膏剂,其制备方法是:(1)取葛根、车前子、淡竹叶、丝瓜络、金钱草,去杂质,洗净,用清水浸润,切片,置于酒液中洗浸7小时,日晒七天、晚上放置在户外七晚为一次制备过程,如此连续9次后再晒干备用;将黄酒和蜂蜜水混匀制成混合液,托盘片蘸混合液后置于火上焙干,重复操作三次,最后一次焙干后,晾凉;(2)将过木瓜、威灵仙去杂质,洗净,用黄酒煮,待酒吸尽后,取出,用湿草纸包裹三层,置于热灰中,煨至外层纸枯焦时,取出,除去纸,晾干; (3)取羌活、天花粉、川芎、延胡索,去杂质,洗净,用姜汁拌匀,浸润 20 分钟,取出,放入锅中隔水蒸15分钟,取出,晾干;步骤(4)与步骤(1)(2)(3)所制原料药一起加水煎煮(加水量为总原料药质量的8倍),大火煮沸后小火煎,过滤,收集药液,药渣加水再次煎煮,合并两次所得药液;加所煮原料药质量8倍的水煎煮,共煎煮三次,每次大火煮开后小火煎 30-40分钟,过滤,合并三次所得滤液, 浓缩,干燥,粉碎,制成干燥物粉;(5)将步骤(1)(2)(3)所制原料药一起粉碎过100-160目筛(优选的,粉碎过120-140目筛;更加优选的,粉碎过130目筛),并与步骤(4)所制干燥物粉混匀,得到药粉,加白酒泛制成丸,即得丸剂。
颗粒剂的其制备方法为 :(1)取葛根、车前子、淡竹叶、丝瓜络、金钱草,去杂质,洗净,用清水浸润,切片,置于酒液中洗浸7小时,日晒七天、晚上放置在户外七晚为一次制备过程,如此连续9次后再晒干备用;(2)将薏米仁、木瓜、威灵仙,去杂质,洗净,用黄酒煮,待酒吸尽后,取出,用湿草纸包裹三层,置于热灰中,煨至外层纸枯焦时,取出,除去纸,晾干 ;(3)将羌活、天花粉、川芎、延胡索,去杂质,洗净,用黄酒将车前子拌匀,用文火炒至略带火色。每100kg羌活用黄酒12.5kg。加所煮原料药质量 8倍的水煎煮,共煎煮三次,每次大火煮开后小火煎30-40分钟(优选的,小火煎 32-38分钟;更加优选的,小火煎35分钟),过滤,合并三次所得滤液,浓缩,干燥,制成干燥物粉;滤液浓缩至相对密度为1.30~1.50的清膏,喷雾干燥,加入白糖和糊精等颗粒剂用辅料,混匀,以75%乙醇制粒,干燥后喷入提取出来得挥发油,混匀,即得制得浸膏干粉,对所得的浸膏干粉进行造粒,干燥分装后即可得到颗粒剂。
本发明提供的治疗痛风的中药制剂组方科学,各种剂型的制备方法简单,所得产品服用方便、便于携带。除此之外,本发明的优良效果还表现在:
1、本发明具有疗效好,疗程短,无不良反应,防复发等优点;
2、本发明为纯中药制剂,药材廉价易得,无任何毒副作用,易接受;
3、本组方完全符合中医“治病必求于本”治疗原则,具有清热利湿、祛风止痛等功效,可根治痛风。
4、注意事项:治疗期间(1)要做到忌口(海鲜、动物内脏、火锅、豆制品、草鱼、啤酒、各种高汤、菠菜等高嘌呤食品);(2)多喝白开水;(3)多运动。
诊断标准 :1、多以单个趾指关节猝然红肿疼痛,逐渐痛剧如虎咬,昼轻夜甚,反复发作。可伴发热、头痛等症状;
2、常因劳累,暴饮暴食,吃高嘌呤食物,饮酒及外感风寒等诱发;
3、初起可单关节发病,以第 1 跖趾关节为多见。继则足踝、跟、手指和其他小关节出现红肿热痛,甚则关节腔可渗液。反复发作后,可伴有关节周围及耳廓、耳轮及趾、指骨间出现“块瘰”(痛风石);
4、血尿酸、尿尿酸增高,发作期白细胞总数可增高 ;
5、必要时做肾B超、尿常规、肾功能等检查,以了解痛风后肾脏病变情况。X 线摄片检查:可示软骨缘邻近关节的骨质有不整齐的穿凿样圆形缺损。
疗效情况判定标准:
治愈:临床症状消失,关节功能恢复正常,血及尿液中尿酸含量正常,肾功能正常,停药后两年未复发;
有效 :临床症状改善,关节功能改善,血及尿液中尿酸含量明显降低或接近正常,肾功能好转;
无效 :临床症状无改善,理化指标检查无变化。
典型病例1(丸剂):
患者余某,男性,46 岁,患者左足趾、足背反复性肿痛 6年。患者 3 年前在一次饮酒后,突然发生左足背,大拇指肿痛,难以入睡,局部灼热红肿。服用消炎止痛药后,一周后疼痛缓解。每遇饮酒或感冒后即易发作,自服新黄片、苏打片。服药效果不佳,疼痛固定于左足背及左拇指。一月前又因酒后卧睡受凉而引起本病发作,查体:面红,颇行,左足背及拇指红、肿、压痛、功能受限。舌质红,苔黄腻,脉弦滑数。化验:血沉 80 ㎜ /h,血尿酸 655μmol/L。
自服用本发明实施例所制备的丸剂一个疗程后,疼痛发作时痛感轻、查体化验血尿酸含量将至 540μmol/L,坚持服用本制剂两个月后,查体化验血尿酸含量将至 376μmol/L,血尿酸为正常范围值中的高值水平。继续服用本制剂一个月,痛风一年未发,查体化验血尿酸为 295μmol/L,血尿酸为正常水平。
典型病例2(颗粒剂):
患者李某,女,42 岁,因多关节痛8年,加重2个月。8年前,患者突发右第一跖趾关节红肿热痛,后逐渐累及左第一跖趾关节、双踝、双膝、双腕关节,间歇期无不适。医院查尿酸增高586 mm/h,血沉波动在 94-122mm/h,关节穿刺液可见痛风结晶,诊断为痛风石性痛风。 4年前,患者再发多关节疼痛,使用秋水仙碱及非类固醇类抗炎药 (NSAID) 效果不佳,予以泼尼松 20mg/d 治疗后疼痛缓解;随后予以别嘌醇治疗,因过敏综合征而停用,丙磺舒500mg bid 治疗效果不明显,因肾结石而停用。2 个月前,患者多关节肿痛发作频繁,服用泼尼松20mg/d,仍有发作,前来治疗。
服用本发明实施所制备的颗粒剂2 个月后,各关节红肿消退,关节活动自如, 用药期间,没有发生过敏反应。继续服用本制剂 2个月,期间疼痛发作次数很少。坚持服用四个月后,查体化验,血尿酸值为 350μmol/L,恢复至血尿酸正常范围值,一年且无复发迹象。
(汤剂治疗) 临床资料:
1、一般资料
选择2016年2月-2016年12月在我院接受治疗的100例患者,年龄在26~65岁之间,其中男66例、女44例,两组病人在性别、年龄、病程、治疗前症状等方面经统计学分析均无显著性差异,具有可比性。
2、中医辨证标准
脾虚湿阻证:无症状期,或仅有轻微的关节症状,伴有高尿酸血症,或见身困倦怠,腰膝酸痛,纳食减少,脘腹胀闷,舌质淡胖或舌尖红,苔白或苔黄厚腻,脉细或弦滑等。
3、分组方法
将100例病人随机分成2组,其中治疗组50例,对照组50例。治疗组和对照组在常规治疗的基础上加以治疗,治疗组使用本发明的中药制剂,每日一剂,连用三十天。
4、治疗方法
基础治疗(一)急性发作期要卧床休息,抬高患肢,注意保护受累关节;(二)低嘌呤饮食,禁酒;(三)饮足够的水,每日2000ml以上。
治疗组在基础治疗的基础上口服本发明所述的中药制剂。其组方为:葛根、车前子、淡竹叶、丝瓜络、金钱草、薏米仁、木瓜、威灵仙、按传统方法制成汤剂,早晚温服,每日一剂。
对照组:基础治疗的基础上口服别嘌呤醇。两组均已三十天为一个疗程。
治疗结果:两组病人总疗效分析结果如下表
从上表可知,治疗后,治疗组总有效率达98%,对照组总有效率达60%,由此可知治疗组疗效明显好于对照组。
前述对本发明的具体示例性实施方案的描述是为了说明和例证的目的。这些描述并非想将本发明限定为所公开的精确形式,并且很显然,根据上述教导,可以进行很多改变和变化。对示例性实施例进行选择和描述的目的在于解释本发明的特定原理及其实际应用,从而使得本领域的技术人员能够实现并利用本发明的各种不同的示例性实施方案以及各种不同的选择和改变。本发明的范围意在由权利要求书及其等同形式所限定。本领域的普通技术人员,以本发明所明确公开的或根据文件的书面描述毫无异议的得到的,均应认为是本专利所要保护的范围。
Claims (7)
1.一种治疗痛风的中药,其特征在于该中药的重量组份为: 葛根 10-40、车前子5-20、淡竹叶5-20、丝瓜络5-20、金钱草8-20。
2.根据权利要求1所述治疗痛风的中药,其特征在于该中药的重量组份还包括: 葛根10-40、车前子5-20、淡竹叶5-20、丝瓜络5-20、金钱草8-20、薏米仁10-40、木瓜8-20、威灵仙8-20。
3.根据权利要求2所述治疗痛风的中药,其特征在于该中药的重量组份进一步还包括:葛根 10-40、车前子8-20、淡竹叶8-20、丝瓜络8-20、金钱草8-20、薏米仁10-40、木瓜8-20、威灵仙8-20、羌活10-15、天花粉10-15、川芎10-15、延胡索10-15。
4.根据权利要求1所述治疗痛风的中药,该中药的制备方法,其步骤:取葛根、车前子、淡竹叶、丝瓜络、金钱草,去杂质,洗净,用清水浸润,切片,置于酒液中洗浸7小时,日晒七天、晚上放置在户外七晚为一次制备过程,如此连续9次后再晒干备用;所制原料药一起加水煎煮,大火煮沸后小火煎 25-47分钟,过滤,收集药液,即得汤剂。
5.根据权利要求2所述治疗痛风的中药,该中药的制备方法,其步骤:(1)取葛根、车前子、淡竹叶、丝瓜络、金钱草,去杂质,洗净,用清水浸润,切片,置于酒液中洗浸7小时,日晒七天、晚上放置在户外七晚为一次制备过程,如此连续9次后再晒干备用;(2)将薏米仁、木瓜、威灵仙,去杂质,洗净,用黄酒煮,待酒吸尽后取出,用湿草纸包裹三层,置于热灰中,煨至外层纸枯焦时,取出,除去纸,晾干;所制原料药一起加水煎煮,大火煮沸后小火煎 25-47分钟,过滤,收集药液,即得汤剂。
6.根据权利要求3所述治疗痛风的中药,该中药的制备方法,其步骤:(1)取葛根、车前子、淡竹叶、丝瓜络、金钱草,去杂质,洗净,用清水浸润,切片,置于酒液中洗浸7小时,日晒七天、晚上放置在户外七晚为一次制备过程,如此连续9次后再晒干备用;(2)将薏米仁、木瓜、威灵仙,去杂质,洗净,用黄酒煮,待酒吸尽后取出,用湿草纸包裹三层,置于热灰中,煨至外层纸枯焦时,取出,除去纸,晾干;(3)将羌活、天花粉、川芎、延胡索,去杂质,洗净,用黄酒将车前子拌匀,用文火炒至略带火色;每100kg羌活用黄酒12.5kg;步骤(4)与步骤(1)(2)(3)所制原料药一起加水煎煮,大火煮沸后小火煎 25-47分钟,过滤,收集药液,即得汤剂。
7.根据权利要求4-6所述治疗痛风的中药,其特征在于:所述中药剂型为汤剂、胶囊剂、颗粒剂或丸剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710077470.1A CN106668607A (zh) | 2017-02-14 | 2017-02-14 | 一种治疗痛风的中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710077470.1A CN106668607A (zh) | 2017-02-14 | 2017-02-14 | 一种治疗痛风的中药 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106668607A true CN106668607A (zh) | 2017-05-17 |
Family
ID=58861585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710077470.1A Pending CN106668607A (zh) | 2017-02-14 | 2017-02-14 | 一种治疗痛风的中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106668607A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107496762A (zh) * | 2017-09-20 | 2017-12-22 | 贵阳健圣堂药材有限公司 | 一种降低高尿酸预防改善痛风的保健茶及其制备方法和应用 |
CN111759934A (zh) * | 2020-07-02 | 2020-10-13 | 咸银库 | 一种降尿酸的中药配方及其制备工艺 |
CN113018391A (zh) * | 2021-04-07 | 2021-06-25 | 西双版纳傣密药业有限公司 | 一种治疗痛风的中药配方及其制备方法 |
CN113288975A (zh) * | 2021-04-13 | 2021-08-24 | 隋新 | 一种治疗痛风疾病的中药及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104940423A (zh) * | 2015-06-30 | 2015-09-30 | 天峨县平昌生态农业有限公司 | 一种治疗痛风的中药制剂 |
-
2017
- 2017-02-14 CN CN201710077470.1A patent/CN106668607A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104940423A (zh) * | 2015-06-30 | 2015-09-30 | 天峨县平昌生态农业有限公司 | 一种治疗痛风的中药制剂 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107496762A (zh) * | 2017-09-20 | 2017-12-22 | 贵阳健圣堂药材有限公司 | 一种降低高尿酸预防改善痛风的保健茶及其制备方法和应用 |
CN111759934A (zh) * | 2020-07-02 | 2020-10-13 | 咸银库 | 一种降尿酸的中药配方及其制备工艺 |
CN113018391A (zh) * | 2021-04-07 | 2021-06-25 | 西双版纳傣密药业有限公司 | 一种治疗痛风的中药配方及其制备方法 |
CN113288975A (zh) * | 2021-04-13 | 2021-08-24 | 隋新 | 一种治疗痛风疾病的中药及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106668607A (zh) | 一种治疗痛风的中药 | |
CN102274453B (zh) | 一种治疗糖尿病的中药及其制备方法 | |
CN103536778B (zh) | 一种治疗偏头痛的中药制剂 | |
CN102362983A (zh) | 一种治疗眩晕的中药组合物 | |
CN100544763C (zh) | 一种治疗冠心病的中药 | |
CN105497816A (zh) | 一种治疗动脉粥样硬化的中药制剂及其制备方法 | |
CN102441136B (zh) | 治疗脑水肿的中药组合物及其制备方法 | |
CN102423433A (zh) | 一种用于治疗银屑病的中药混合物 | |
CN105079676A (zh) | 一种治疗脂肪肝的药物及其制备方法 | |
CN102579975B (zh) | 一种治疗银屑病的中药混合物 | |
CN104306929A (zh) | 一种治疗重症急性胰腺炎的中药配方及其制备方法 | |
CN102406865A (zh) | 一种治疗银屑病的中药组合物 | |
CN102416117A (zh) | 一种治疗银屑病的中成药 | |
CN104606571A (zh) | 一种生津止渴鲜菠菜根代茶饮及制备方法 | |
CN103877356B (zh) | 一种治疗心肌梗死的中药制剂及制备方法 | |
CN103520644B (zh) | 用于治疗痰瘀型高脂血症的中药组合物及其制备方法 | |
CN102423458A (zh) | 一种用于治疗银屑病的中成药 | |
CN102631481B (zh) | 一种治疗病毒性肝炎的中药制剂 | |
CN104888060A (zh) | 治疗痛风的中药剂 | |
CN106692858A (zh) | 一种治疗胎动不安的药物及其制备方法 | |
CN104906467A (zh) | 一种治疗痛风的中药组合物及其制法 | |
CN103191277B (zh) | 一种治疗气滞证型胆结石的中药汤剂 | |
CN105288184A (zh) | 主治抑郁症的中药组合物及制法 | |
CN104857242A (zh) | 一种治疗小儿疳积的健脾消食剂及制备方法 | |
CN103751604A (zh) | 一种治疗肺阴亏耗型高脂血症的中药制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170517 |
|
WD01 | Invention patent application deemed withdrawn after publication |